Daniel M. Geynisman, MD

Daniel M. Geynisman, MD, Chief of the Division of Genitourinary Medical Oncology, Fox Chase Cancer Center

Articles by Daniel M. Geynisman, MD

CheckMate 274: Estimating the Underlying Cure Fraction for Patients With High-Risk MIUC

Daniel M. Geynisman, MDASCO GU Symposium 2024 | January 30, 2024

Dr. Geynisman highlights the CheckMate 274 study into long-term survival following treatment with adjuvant nivolumab.

RETAIN: Risk-Enabled Therapy After Neoadjuvant Chemo for MIBC

Daniel M. Geynisman, MDASCO GU Symposium 2023 | February 24, 2023

Daniel M. Geynisman, MD, explains the results and utility of the RETAIN trial for bladder sparing in patients with MIBC.